EK

Elena N. Klyushnenkova

OT Osiris Therapeutics: 6 patents #12 of 76Top 20%
OU Oregon Health & Science University: 1 patents #352 of 725Top 50%
UM University Of Maryland: 1 patents #209 of 857Top 25%
📍 Baltimore, MD: #549 of 4,923 inventorsTop 15%
🗺 Maryland: #4,710 of 35,612 inventorsTop 15%
Overall (All Time): #743,805 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
8435507 Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer Richard B. Alexander, Jason Link, Arthur A. Vandenbark 2013-05-07
7491388 Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation Kevin R. Mc Intosh, Joseph D. Mosca 2009-02-17
6875430 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation Kevin R. McIntosh, Joseph D. Mosca 2005-04-05
6685936 Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation Kevin R. McIntosh 2004-02-03
6368636 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation Kevin R. McIntosh, Joseph D. Mosca 2002-04-09
6328960 Mesenchymal stem cells for prevention and treatment of immune responses in transplantation Kevin R. McIntosh, Joseph D. Mosca 2001-12-11
6281012 Method of preparing suppressor T cells with allogeneic mesenchymal stem cells Kevin R. McIntosh 2001-08-28